These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 10487628)

  • 1. Trends in cancer of the cervix uteri in Sweden following cytological screening.
    Bergström R; Sparén P; Adami HO
    Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.
    Smith HO; Tiffany MF; Qualls CR; Key CR
    Gynecol Oncol; 2000 Aug; 78(2):97-105. PubMed ID: 10926787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P; Kallio M; Hakama M
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
    Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening on the incidence of cervical cancer in Alberta.
    Starreveld AA; Hill GB; Brown LB; Koch M
    Can Med Assoc J; 1981 Nov; 125(10):1105-9. PubMed ID: 7326641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
    Robertson JH; Woodend B
    Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
    Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
    Sherman ME; Wang SS; Carreon J; Devesa SS
    Cancer; 2005 Mar; 103(6):1258-64. PubMed ID: 15693030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of the uterine cervix in Norway by histologic type, 1970-84.
    Eide TJ
    J Natl Cancer Inst; 1987 Aug; 79(2):199-205. PubMed ID: 3474452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000.
    Visioli CB; Zappa M; Ciatto S; Iossa A; Crocetti E
    Cancer Detect Prev; 2004; 28(6):461-4. PubMed ID: 15582270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pap-smear history of women with invasive cervical squamous carcinoma. A case-control study from Sweden.
    Andersson-Ellström A; Seidal T; Grannas M; Hagmar B
    Acta Obstet Gynecol Scand; 2000 Mar; 79(3):221-6. PubMed ID: 10716304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of the Leiden mass screening for cervix uteri carcinoma; the 'young' (24-34 years) versus the 'old' (35-54 years) group of women].
    Boon ME; de Graaff Guilloud-Gentenaar JC; Beck S
    Ned Tijdschr Geneeskd; 1990 Aug; 134(32):1545-9. PubMed ID: 2392176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of cancer of the cervix: global and national perspective.
    Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
    J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytological screening history of patients with early invasive cervical cancer.
    Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
    Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.